Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Birgit Otzen Petersen has worked on the following 5 EPO patent applications which have been published in the last five years:

EP13720714

HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS

IPC classification:
C07K 16/28
Applicant:
Novo Nordisk A/S
Applicant:
Amgen Inc
Agent:
Birgit Otzen Petersen, Novo Nordisk A/S
Status:
EXAMINATION IN PROGRESS
EP14708903

GROWTH HORMONE COMPOUNDS

IPC classification:
C07K 19/00, C12N 5/10, C12P 21/02
Applicant:
Novo Nordisk Health Care AG
Agent:
Birgit Otzen Petersen, Novo Nordisk A/S
Status:
EXAMINATION IN PROGRESS
EP14715022

GROWTH HORMONE COMPOUND FORMULATION

IPC classification:
A61K 38/27, A61K 47/10, A61K 47/18, A61K 47/26, A61K 47/48
Applicant:
Novo Nordisk Health Care AG
Agent:
Birgit Otzen Petersen, Novo Nordisk A/S
Status:
EXAMINATION REQUESTED
EP11731397

GROWTH HORMONE CONJUGATES

IPC classification:
A61K 47/48, A61P 5/06
Applicant:
Novo Nordisk Health Care AG
Agent:
Birgit Otzen Petersen, Novo Nordisk A/S
Status:
APPLICATION WITHDRAWN
EP14818938

METHOD FOR THIOETHER CONJUGATION OF PROTEINS

IPC classification:
A61K 47/48, C07K 14/00
Applicant:
Novo Nordisk Health Care AG
Agent:
Birgit Otzen Petersen, Novo Nordisk A/S
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature